The Preserved Network Technology
The first* resilient hyaluronic acid (HA) range specifically designed to accompany facial dynamics
To naturally integrate into facial structures, an HA filler has to be able to resist pressure and seamlessly follow facial TEOSYAL RHA®** is the first* range movements of HA fillers with rheological properties specifically designed to follow the expression of the face. It results from a unique and innovative technology that better preserves the natural chains of the HA molecules1 to create a gel that mimics the natural HA within our skin.
The TEOSYAL RHA® portfolio of dermal fillers provides a selection of HA gels that covers a range of aesthetic needs from superficial dynamic wrinkles, through volume in extended areas for correction of facial wrinkles and folds.
The clinical efficacy and safety of the products was highlighted in an 18-month comparative study2. The study looked at the immediate and long-term efficacy of the gel as well as patient satisfaction2. This award-winning filler works in synchronisation with facial expressions to provide a natural looking result, whilst remaining undetectable3.
*At Teoxane Laboratories.
**TEOSYAL RHA® 1 to 4 are trademark of the firm TEOXANE SA. These products are gels that contain hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. TEOSYAL RHA® 1 to 4 are class III medical devices and are regulated health product bearing the CE marking (CE2797) under this regulation. For professional use only. Please refer to instructions for use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effects or any claim as soon as possible to the following address: email@example.com.
1. Report, Rheological characterisations of hyaluronic acid gels. Rheonovia (University of Grenoble, France).
2. Rzany et alet al., 2019, Dermatol Surg. doi: 10.1097/DSS.0000000000001971.
3. International post-market survey. 80 Doctors. 2015-08. Internal data. 6.
Kenne L, et al.Carbohydrate Polymers. 2013; 91: 410–8.
+.Crosslinked BDDE = BDPE = 1,4-butanediol di-(propan-2,3-diolyl) ether
++MoD: degree of modification.